Search Clear search
SearchSite Search

Financial figures

Overview of DSM's latest financial key figures

Key financials

Presented below are DSM's net sales, balance sheet, income statement and cash flow statement as at FY 2022*.

* From Q1 2021 onwards, in line with the established practice of many of DSM's consumer ingredients peers, we provide trading updates for Q1 and Q3 reporting sales, organic growth, Adjusted EBITDA and Adjusted EBITDA margins.

We report full financial details for half year and full year results and host calls for the media and analysts for both.

Net sales

in € million

Year Q1 Q2 Q3 Q4 Total
2022 2,008¹ 2,107¹ 2,182¹ 2,093¹ 8,390¹
2021 1,727¹ 1,790¹ 1,825¹ 1,928¹ 7,269¹
2020 2,045² 2,020² 1,961² 2,080² 8,106²
2019 2,021² 2,008² 2,035² 1,934² 7,998²
2018 2,435 2,359 2,265 2,208 9,267
2017 2,159 2,161 2,136 2,176 8,632
2016 1,913 1,994 1,998 2,015 7,920
2015 1,886 1,754 2,102 1,926 7,722
2014 2,298 2,288 2,323 2,175 9,181
2013 2,376 2,468 2,397 2,377 9,618
2012 2,290 2,268 2,304 2,269 9,131
2011 2,234 2,265 2,322 2,227 9,048
2010 1,933 2,120 2,041 2,082 8,176
2009 1,578 1,664 1,725 1,758 6,725
2008 2,303 2,406 2,336 2,034 9,079

¹ Figures reflect continuing operations which include DSM’s Health, Nutrition & Bioscience and Corporate Activities. In May 31, 2022 DSM announced the sale of DSM Protective Materials and DSM Engineering Materials. All of DSM’s Materials businesses were reclassified to discontinued operations.

²  Figures reflect the reclassification of the DSM’s Resins & Functional Materials businesses to discontinued operations. The sale with an equity value of €1.6 billion was subsequently finalized on 01 April 2021.

Balance sheet FY 2022

Assets in € million Year-end 2022 Year-end             2021
Intangible Assets 5,147 5,309
Property, Plant & Equipment 3,576 3,964
Deferred Tax Assets 95 203
Employee benefits 19 75
Share in Associates & Joint Ventures 61 64
Financial derivatives 82 48
Other Financial Assets 295 227
Non-Current Assets 9,275 9,890
Inventories 2,239 2,297
Trade Receivables 1,508 1,604
Income tax receivables 36 61
Other Current Receivables 78 32
Financial Derivatives 42 30
Current Investments 125 489
Cash & Cash Equivalents 2,755 1,561
Sub-total 6,883 6,074
Assets Held for Sale 1,245 56
Current Assets 8,128 6,130
Total Assets 17,403 16,020
Shareholders' Equity 10,743 9,318
Non-controlling interest 102 79
Equity 10,845 9,397
Deferred Tax Liabilities 476 490
Employee Benefits Liabilities 241 323
Provisions 74 96
Borrowings 2,978 2,995
Financial derivatives 4 9
Other Non-current Liabilities 205 280
Non-current liabilities 3,978 4,193
Employee Benefits 22 21
Provisions 50 68
Borrowings 86 103
Financial Derivatives 23 40
Trade Payables 1,415 1,571
Income tax payable 64 77
Other Current Liabilities 490 540
Sub-total 2,150 2,420
Liabilities associated with the assets held for sale 430 10
Current Liabilities 2,580 2,430
Total Equity and Liabilities 17,403 16,020
Net debt 87 1,019
Equity/Total Assets  62% 59%

Income statement FY 2022

Continuing operations in € million FY 2022 FY 2021
Sales 8,390 7,269
Gross margin 2,690 2,612
Operating profit (EBIT) 682 711
Financial income and expense -88 -100
Profit before income tax expense 594 611
Income tax expense -124 -123
Share of the profit of associates/
joint control entities		 5 342
Net profit from continuing operations 475 830
Net profit from discontinuing operations 1,240 850
Net profit for the period 1,715 1,680
Of which:    
Attributable to non-controlling interests 15 4
Dividend on cumulative preference shares 6 4
Available to holders of ordinary shares 1,694 1,670

Cash flow statement FY 2022

in € million FY 2022 FY 2021
 Cash, Cash Equivalents and Current Investments (at beginning of period)  1,561 871
 Operating Activities     
 EBITDA  2,646 2,370
 Change in Working  Capital  -497 -144
 Income Tax   -131 -133
Proceeds divestments -1,031 -640
 Other  -22 -26
 Cash provided by Operating Activities (Operating cash flow)   965 1,427
 of which provided by continuing operations   775 1,040
 Investing Activities     
 Capital Expenditures   -644 -570
 Payments regarding drawing rights  -7 -7
 Acquisitions  -74  -704
 Disposal of Subsidiaries, Businesses & Associates  1,366 1,791
 Disposal of Other Non-current Assets  47 150
 Change in Fixed-term Deposits  363 -445
 Interest Received  6 5
 Dividend and capital (re)payments   -29 -31
 Other  -152 19
 Cash used in Investing Activities  876 208
 Financing Activities     
Dividend  -345 -266
 Interest Paid   -52 -65
 Repurchase of shares  -210 -165
 Proceeds from re-issued treasury shares  25 34
 Proceeds from / repayments of corporate bonds    -500
 Payment of lease liabilities  -57 -54
 Other Cash from/ used in Financing Activities   -6 32
 Cash from / used in Financing Activities -645 -984
 Exchange Differences  -2 39
 Cash and Cash Equivalents (end of period)  2,755 1,561

Read more